Wally Brisson

Wally Brisson is an accomplished leader in the biopharmaceutical and manufacturing sectors, currently serving as the Director of Chemistry, Manufacturing, and Controls at Life Edit Therapeutics since June 2023. Prior experience includes a senior director role at StrideBio, Inc., where operational strategies for manufacturing science were developed. Wally has held key positions at Medicago, Seqirus, Hospira, Catalent Pharma Solutions, Covidien, Novo Nordisk, and GlaxoSmithKline Pharma GmbH, consistently delivering results in manufacturing operations, process engineering, and operational excellence across various therapeutic areas. Wally holds a Bachelor's degree in Industrial Engineering from North Carolina State University and a Bachelor's degree in Business Management and Economics from the University of North Carolina at Pembroke.